| Volume One |
|
|
Part I Foundations Of Cardiovascular Medicine |
|
|
|
1 Cardiovascular Disease: Past, Present, And Future |
|
|
1 | (13) |
|
|
|
2 Global Burden Of Cardiovascular Disease |
|
|
14 | (17) |
|
|
|
|
|
|
|
3 Impact Of The Environment On Cardiovascular Health |
|
|
31 | (11) |
|
|
|
|
|
4 Clinical Trials In Cardiovascular Medicine |
|
|
42 | (11) |
|
|
|
|
|
5 Clinical Decision-Making In Cardiology |
|
|
53 | (9) |
|
|
|
|
|
6 Impact Of Health Care Policy On Quality, Outcomes, And Equity In Cardiovascular Disease |
|
|
62 | (9) |
|
|
|
Part II Individualizing Approaches To Cardiovascular Disease |
|
|
|
7 Applications Of Genetics To Cardiovascular Medicine |
|
|
71 | (16) |
|
|
|
|
|
8 Proteomics And Metabolomics In Cardiovascular Medicine |
|
|
87 | (5) |
|
|
|
9 Principles Of Drug Therapeutics, Pharmacogenomics, And Biologics |
|
|
92 | (10) |
|
|
|
10 Biomarkers And Use In Precision Medicine |
|
|
102 | (7) |
|
|
|
|
|
11 Artificial Intelligence In Cardiovascular Medicine |
|
|
109 | (8) |
|
|
|
|
|
|
|
|
|
12 Wearable Devices In Cardiovascular Medicine |
|
|
117 | (6) |
|
|
|
Part III Evaluation Of The Patient |
|
|
|
13 History And Physical Examination: An Evidence-Based Approach |
|
|
123 | (18) |
|
|
|
|
|
|
|
141 | (34) |
|
|
|
|
|
15 Exercise Physiology And Exercise Electrocardiographic Testing |
|
|
175 | (21) |
|
|
|
|
|
|
|
196 | (72) |
|
|
|
|
|
|
|
17 Chest Radiography In Cardiovascular Disease |
|
|
268 | (9) |
|
|
|
|
|
277 | (37) |
|
|
|
|
|
19 Cardiovascular Magnetic Resonance Imaging |
|
|
314 | (21) |
|
|
|
20 Cardiac Computed Tomography |
|
|
335 | (28) |
|
|
|
21 Coronary Angiography And Intravascular Imaging |
|
|
363 | (22) |
|
|
|
|
|
22 Invasive Hemodynamic Diagnosis Of Cardiac Disease |
|
|
385 | (25) |
|
|
|
|
|
|
|
23 Anesthesia And Noncardiac Surgery In Patients With Heart Disease |
|
|
410 | (15) |
|
|
|
|
|
Part IV Preventive Cardiology |
|
|
|
24 The Vascular Biology Of Atherosclerosis |
|
|
425 | (17) |
|
|
|
25 Primary Prevention Of Cardiovascular Disease |
|
|
442 | (29) |
|
|
|
|
|
|
|
26 Systemic Hypertension: Mechanisms, Diagnosis, And Treatment |
|
|
471 | (31) |
|
|
|
|
|
27 Lipoprotein Disorders And Cardiovascular Disease |
|
|
502 | (23) |
|
|
|
|
|
|
|
28 Cardiovascular Disease Risk Of Nicotine And Tobacco Products |
|
|
525 | (6) |
|
|
|
29 Nutrition And Cardiovascular And Metabolic Diseases |
|
|
531 | (16) |
|
|
|
30 Obesity: Medical And Surgical Management |
|
|
547 | (9) |
|
|
|
|
|
|
|
31 Diabetes And The Cardiovascular System |
|
|
556 | (23) |
|
|
|
|
|
|
|
32 Exercise And Sports Cardiology |
|
|
579 | (9) |
|
|
|
|
|
33 Comprehensive Cardiac Rehabilitation |
|
|
588 | (5) |
|
|
|
34 Integrative Approaches To The Management Of Patients With Heart Disease |
|
|
593 | (6) |
|
|
|
Part V Atherosclerotic Cardiovascular Disease |
|
|
|
35 Approach To The Patient With Chest Pain |
|
|
599 | (10) |
|
|
|
|
|
36 Coronary Blood Flow And Myocardial Ischemia |
|
|
609 | (27) |
|
|
|
|
|
37 St-Elevation Myocardial Infarction: Pathophysiology And Clinical Evolution |
|
|
636 | (26) |
|
|
|
|
|
|
|
38 St-Elevation Myocardial Infarction: Management |
|
|
662 | (52) |
|
|
|
|
|
39 Non-ST Elevation Acute Coronary Syndromes |
|
|
714 | (25) |
|
|
|
|
|
40 Stable Ischemic Heart Disease |
|
|
739 | (47) |
|
|
|
|
|
41 Percutaneous Coronary Intervention |
|
|
786 | (20) |
|
|
|
|
|
|
|
806 | (31) |
|
|
|
|
|
43 Peripheral Artery Diseases |
|
|
837 | (22) |
|
|
|
|
|
44 Treatment Of Noncoronary Obstructive Vascular Disease |
|
|
859 | (11) |
|
|
|
|
|
45 Prevention And Management Of Ischemic Stroke |
|
|
870 | (19) |
|
|
| Volume Two |
|
|
|
|
|
46 Mechanisms Of Cardiac Contraction And Relaxation |
|
|
889 | (24) |
|
|
|
|
|
47 Pathophysiology Of Heart Failure |
|
|
913 | (20) |
|
|
|
|
|
48 Approach To The Patient With Heart Failure |
|
|
933 | (13) |
|
|
|
|
|
49 Diagnosis And Management Of Acute Heart Failure |
|
|
946 | (29) |
|
|
|
|
|
50 Management Of Heart Failure Patients With Reduced Ejection Fraction |
|
|
975 | (32) |
|
|
|
51 Heart Failure With Preserved And Mildly Reduced Ejection Fraction |
|
|
1007 | (24) |
|
|
|
|
|
|
|
52 The Dilated, Restrictive, And Infiltrative Cardiomyopathies |
|
|
1031 | (21) |
|
|
|
|
|
1052 | (10) |
|
|
|
|
|
54 Hypertrophic Cardiomyopathy |
|
|
1062 | (15) |
|
|
|
|
|
|
|
1077 | (14) |
|
|
|
|
|
56 Cardio-Oncology: Managing Cardiotoxic Effects Of Cancer Therapies |
|
|
1091 | (8) |
|
|
|
57 Cardio-Oncology: Approach To The Patient |
|
|
1099 | (8) |
|
|
|
58 Devices For Monitoring And Managing Heart Failure |
|
|
1107 | (12) |
|
|
|
|
|
59 Mechanical Circulatory Support |
|
|
1119 | (13) |
|
|
|
|
|
60 Cardiac Transplantation |
|
|
1132 | (13) |
|
|
|
Part VII Arrhythmias, Sudden Death, And Syncope |
|
|
|
61 Approach To The Patient With Cardiac Arrhythmias |
|
|
1145 | (18) |
|
|
|
|
|
62 Mechanisms Of Cardiac Arrhythmias |
|
|
1163 | (28) |
|
|
|
|
|
63 Genetics Of Cardiac Arrhythmias |
|
|
1191 | (17) |
|
|
|
|
|
|
|
64 Therapy For Cardiac Arrhythmias |
|
|
1208 | (37) |
|
|
|
|
|
65 Supraventricular Tachycardias |
|
|
1245 | (27) |
|
|
|
|
|
66 Atrial Fibrillation: Clinical Features, Mechanisms, And Management |
|
|
1272 | (16) |
|
|
|
|
|
|
|
67 Ventricular Arrhythmias |
|
|
1288 | (24) |
|
|
|
|
|
68 Bradyarrhythmias And Atrioventricular Block |
|
|
1312 | (9) |
|
|
|
|
|
69 Pacemakers And Implantable Cardioverter-Defibrillators |
|
|
1321 | (28) |
|
|
|
|
|
70 Cardiac Arrest And Sudden Cardiac Death |
|
|
1349 | (38) |
|
|
|
|
|
|
|
71 Hypotension And Syncope |
|
|
1387 | (12) |
|
|
|
|
|
|
|
Part VIII Diseases Of The Heart Valves |
|
|
|
|
|
1399 | (20) |
|
|
|
|
|
|
|
|
|
1419 | (11) |
|
|
|
|
|
74 Transcatheter Aortic Valve Replacement |
|
|
1430 | (11) |
|
|
|
|
|
|
|
1441 | (14) |
|
|
|
|
|
1455 | (18) |
|
|
|
|
|
77 Tricuspid, Pulmonic, And Multivalvular Disease |
|
|
1473 | (11) |
|
|
|
|
|
78 Transcatheter Therapies For Mitral And Tricuspid Valvular Heart Disease |
|
|
1484 | (11) |
|
|
|
|
|
79 Prosthetic Heart Valves |
|
|
1495 | (10) |
|
|
|
|
|
80 Infectious Endocarditis And Infections Of Indwelling Devices |
|
|
1505 | (26) |
|
|
|
|
|
|
|
|
|
|
|
1531 | (10) |
|
|
|
Part IX Diseases Of The Myocardium, Pericardium, And Pulmonary Vasculature Bed |
|
|
|
82 Congenital Heart Disease In The Adolescent And Adult |
|
|
1541 | (46) |
|
|
|
|
|
|
|
|
|
83 Catheter-Based Treatment Of Congenital Heart Disease In Adults |
|
|
1587 | (6) |
|
|
|
|
|
|
|
84 Cardiomyopathies Induced By Drugs Or Toxins |
|
|
1593 | (10) |
|
|
|
|
|
85 Cardiovascular Abnormalities In HIV-Infected Individuals |
|
|
1603 | (12) |
|
|
|
|
|
|
|
1615 | (20) |
|
|
|
|
|
|
|
87 Pulmonary Embolism And Deep Vein Thrombosis |
|
|
1635 | (21) |
|
|
|
|
|
88 Pulmonary Hypertension |
|
|
1656 | (22) |
|
|
|
89 Sleep-Disordered Breathing And Cardiac Disease |
|
|
1678 | (9) |
|
|
|
Part X Cardiovascular Disease In Select Populations |
|
|
|
90 Cardiovascular Disease In Older Adults |
|
|
1687 | (23) |
|
|
|
|
|
|
|
|
|
91 Cardiovascular Disease In Women |
|
|
1710 | (13) |
|
|
|
|
|
92 Pregnancy And Heart Disease |
|
|
1723 | (20) |
|
|
|
|
|
93 Heart Disease In Racially And Ethnically Diverse Populations |
|
|
1743 | (8) |
|
|
|
|
|
Part XI Cardiovascular Disease And Disorders Of Other Organs |
|
|
|
94 Endemic And Pandemic Viral Illnesses And Cardiovascular Disease: Influenza And Covid-19 |
|
|
1751 | (15) |
|
|
|
|
|
|
|
95 Hemostasis, Thrombosis, Fibrinolysis, And Cardiovascular Disease |
|
|
1766 | (25) |
|
|
|
96 Endocrine Disorders And Cardiovascular Disease |
|
|
1791 | (18) |
|
|
|
97 Rheumatic Diseases And The Cardiovascular System |
|
|
1809 | (20) |
|
|
|
98 Tumors Affecting The Cardiovascular System |
|
|
1829 | (12) |
|
|
|
|
|
|
|
99 Psychiatric And Psychosocial Aspects Of Cardiovascular Disease |
|
|
1841 | (12) |
|
|
|
|
|
|
|
|
|
100 Neuromuscular Disorders And Cardiovascular Disease |
|
|
1853 | (20) |
|
|
|
|
|
|
|
101 Interface Between Renal Disease And Cardiovascular Illness |
|
|
1873 | (20) |
|
|
|
102 Cardiovascular Manifestations Of Autonomic Disorders |
|
|
1893 | |
|
|
|
|
Lisainfo e-raamatute kohta